September 06, 2012
1 min read
Save

Skin age analysis program measured results of facial treatments

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

A self-assessment software program may serve as a resource for patients who want to measure the effects of neurotoxins and dermal fillers as facial treatments regarding decreases in apparent age, according to study results.

Researchers evaluated four women (mean age, 52 years) using the Home of Younger Skin (HOYS) program, a software application that assesses skin age in seven facial regions and “develops treatment plans allowing patients and staff to track the progress of the treatments delivered.” The program included 35 subregions and displayed images from typical patients aged 25, 35, 45, 55 or 65 years that reflected five grades of aging. After treatments, while using HOYS, patients checked their appearance in a mirror and self-matched the image that most closely represented their own appearance in each subregion. Upon completion, the program generated a report detailing “skin age” for each region.

Program analyses took place before and 6 weeks after treatments. They included volume-enhancing injections of hyaluronic acid and botulinum toxin conducted by an injector masked to the study. No surgical treatments, laser procedures, intense pulsed light or chemical peels to the skin were performed.

Average decrease in apparent full-face skin age was 7.5 years. Individual regions varied with self-reported declines of 13.5 years for the upper face, 9.25 years for the periorbital area, 4.5 years for the mid face and 12.75 years for the lower face. In one patient (aged 39 years) HOYS assessment after treatments to her mid face and nose showed an appearance increase of 2 years.

“When a patient is considering combining rejuvenation strategies, it is useful to have a patient-reported outcome measure such as HOYS to follow their improvement as well as to indicate to both the patient and practitioner their expected improvement in self-perceived skin age with therapy,” the researchers concluded.

Disclosure: Greg J. Goodman owns the HOYS program.